Crinetics Pharmaceuticals, Inc.

General ticker "CRNX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $3.8B (TTM average)

Crinetics Pharmaceuticals, Inc. follows the US Stock Market performance with the rate: 28.6%.

Estimated limits based on current volatility of 4.7%: low 30.48$, high 33.46$

Factors to consider:

  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [29.52$, 64.93$]
  • 2025-12-31 to 2026-12-31 estimated range: [18.39$, 43.28$]

Financial Metrics affecting the CRNX estimates:

  • Negative: Non-GAAP EPS, $ of -3.71 <= 0.04
  • Negative: negative Operating income
  • Negative: Industry operating cash flow per share per price (median), % of -21.10 <= 2.82
  • Negative: Operating cash flow per share per price, % of -4.77 <= 1.79
  • Negative: negative Industry operating income (median)
  • Negative: negative Net income
  • Positive: Interest expense per share, $ of 0 <= 0

Similar symbols

Short-term CRNX quotes

2025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-252025-04-282025-04-292025-04-302025-05-012025-05-022025-05-052025-05-062025-05-072025-05-082025-05-09242628303234
Price $

Long-term CRNX plot with estimates

2030405060Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 2027−1−0.50
CRNXS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $4.74MM $4.01MM $1.04MM
Operating Expenses $172.62MM $226.62MM $339.89MM
Operating Income $-167.88MM $-222.61MM $-338.85MM
Non-Operating Income $3.96MM $8.08MM $40.45MM
Interest Expense $4.32MM $0.00MM $0.00MM
R&D Expense $130.22MM $168.53MM $240.16MM
Income(Loss) $-163.92MM $-214.53MM $-298.41MM
Profit(Loss)* $-159.95MM $-214.53MM $-298.41MM
Stockholders Equity $316.33MM $539.11MM $1,324.81MM
Assets $352.18MM $635.35MM $1,434.59MM
Operating Cash Flow $-115.20MM $-166.31MM $-225.97MM
Capital expenditure $1.66MM $4.69MM $3.84MM
Investing Cash Flow $-173.98MM $-200.41MM $-574.82MM
Financing Cash Flow $121.96MM $388.94MM $1,010.43MM
Earnings Per Share** $-3.08 $-3.69 $-3.69

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.